NSEGeneral Updates3d ago · 2 Sept 2026, 06:30 pm

General Updates

Gufic Biosciences Limited · GUFICBIO

✦ AI SummaryMgmt Change

Gufic Biosciences Limited has informed the Exchange about the promotion and change in designation of two senior management personnel, Ms. Ami Shah as Head-Legal and Mr. Pinak Padhya as President – Sales & Marketing, effective September 02, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gufic Biosciences Limited has informed the Exchange about Promotion and Change in Designation of Senior Management Personnel

Attachments (1)

📄

GUFIC_02092026182917_finalintimation.pdf

pdf

Download →
View document text
259/LG/SE/SEP/2026/GBSL September 02, 2026 To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code : 509079 Scrip Symbol : GUFICBIO Subject : Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Promotion and Change in Designation of Senior Management Personnel Dear Sir/Madam, Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we wish to inform you that, based on the recommendation of Nomination & Remuneration Committee, the Board of Directors, vide Circular Resolution passed today i.e. September 02, 2026 has approved the promotion and consequent change in designation of the following Senior Management Personnel of the Company, with effect from September 02, 2026: 1. Ms. Ami Shah promoted as Head-Legal, while continuing to hold the position of Company Secretary & Compliance Officer, Key Managerial Personnel of the Company 2. Mr. Pinak Padhya - promoted as President – Sales & Marketing The details required under Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed herewith as under: Particulars Ms. Ami Shah Mr. Pinak Padhya Reason for change viz. Promotion of Ms. Ami Shah Promotion of Mr. Pinak Padhya appointment, re-appointment, from Company Secretary, from Vice President – Sales & resignation, removal, death or Compliance Officer and Marketing to President – Sales & otherwise Senior Manager – Legal to Marketing Company Secretary, Compliance Officer and Head- Legal. Date of appointment/re- With effect from September With effect from September 02, appointment/cessation (as 02, 2026 2026 applicable) & term of appointment/re-appointment Brief profile (in case of Ms. Ami Shah is a qualified Mr. Pinak Padhya is a seasoned appointment) Company Secretary and holds pharmaceutical sales and a degree in Law (LL.B.). She marketing professional with has been associated with the over 28 years of leadership Company for over 10 years experience in the and joined the Company as pharmaceutical industry. He is a Company Secretary & Pharmacy Graduate with an Compliance Officer and MBA in Marketing, combining Executive – Legal. strong technical understanding with extensive commercial and She has extensive experience managerial experience. in handling the corporate secretarial affairs of the Over the course of his career, he Company, including has worked with leading corporate governance, pharmaceutical organisations statutory and regulatory including Sun Pharma, Ranbaxy, compliances and matters Glenmark, Elder, Medley and under the Companies Act, Cadila Pharma, gaining broad- 2013, Listing Regulations and based experience in sales, other applicable laws. She marketing, brand management has also gained substantial and business development. He experience in handling legal has handled portfolios across matters, including drafting, multiple therapeutic areas, reviewing and negotiating including Orthopaedics, domestic and international Gastrointestinal, Gynaecology, commercial agreements, Herbal, Dermatology, Pediatrics litigation and court matters, and General Practice. legal notices and providing legal advisory on matters His core areas of expertise relating to the Company’s include strategic brand building, pharmaceutical business and cluster growth, product operations. launches, market expansion and management of multi-therapy Her experience also includes portfolios. He has demonstrated management of the an ability to understand market Company’s intellectual opportunities, develop property matters, including appropriate commercial trademarks, as well as strategies, strengthen customer advising various functions of relationships and lead teams the Company on legal and towards achievement of regulatory matters. She has business objectives. played an active role in strengthening the Company’s His extensive industry legal, governance and experience, diverse therapeutic compliance framework. exposure, strong sales and marketing expertise and proven track record of business growth position him well to assume Prior to joining the Company, enhanced leadership she was associated with the responsibilities and contribute JM Baxi Group as Senior to the Company’s continued Executive – Secretarial Team. growth and expansion. Disclosure of relationships Not Applicable Not Applicable between directors (in case of appointment of director) Kindly take the same on your record. Thanking You, Yours truly, For Gufic Biosciences Limited Ami Shah Company Secretary & Compliance Officer Membership No. A39579